FDA approves Sebclair for seborrheic dermatitis

FDA granted 510(k) clearance to Sebclair from Sinclair (LSE:SPH) to treat seborrheic dermatitis. Chester Valley (Malvern, Penn.) has U.S. marketing rights to the non-steroidal cream and expects to lau...